When Li Qiang conducted research on the development of the biomedical industry in Beijing, he emphasized increasing high-quality scientific and technological supply and policy support, and focusing on promoting the upgrading of the biomedical industry.

On August 20th, Li Keqiang, member of the Politburo Standing Committee of the Communist Party of China and Premier of the State Council, conducted research on the development of the biopharmaceutical industry in Beijing. He emphasized the need to thoroughly implement General Secretary Xi Jinping's important instructions on the development of the biopharmaceutical industry, increase high-quality scientific and technological supply and policy support, fully leverage the role of enterprises as the main drivers of innovation, focus on promoting the quality upgrade of the biopharmaceutical industry, develop and produce more high-quality and efficient new drugs, and continuously enhance the well-being of the people's health.